Search clinical trials for: Trastuzumab emtansine [Kadcyla]
Total 1171 results
-
Henan Cancer HospitalCompletedHER2 Positive Breast CancerChina
-
Hoffmann-La RocheCompletedBreast CancerHungary, Italy, Spain, France, United Kingdom, Belgium, Germany, Portugal, Poland, Canada, Bulgaria, Mexico
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Fudan UniversityNot yet recruiting
-
Fudan UniversityRecruiting
-
Merrimack PharmaceuticalsUnknownBreast CancerUnited States
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
Changhoon YooCompletedCholangiocarcinoma | Biliary Tract Cancer | HER-2 Gene Amplification | HER-2 Protein OverexpressionKorea, Republic of
-
SCRI Development Innovations, LLCEisai Inc.CompletedMetastatic Breast CancerUnited States
-
Fudan UniversityRecruitingTreatment EfficacyChina
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
MedSIRHoffmann-La RocheNot yet recruiting
-
Byondis B.V.CompletedSolid TumorUnited Kingdom, Belgium, Netherlands
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Brain Cancer | Brain MetastasisUnited States
-
Daiichi Sankyo, Inc.Bristol-Myers Squibb; AstraZenecaActive, not recruitingBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
University of Michigan Rogel Cancer CenterCompleted
-
United BioPharmaTri-Service General HospitalCompleted
-
Merrimack PharmaceuticalsCompletedBreast NeoplasmsUnited States
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedBreast Cancer | Breast NeoplasmsUnited States
-
Brown UniversityAstraZenecaRecruitingEsophageal Cancer | Esophageal Adenocarcinoma | HER-2 Protein Overexpression | Gastroesophageal-junction CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Susan G. Komen Breast Cancer FoundationTerminated
-
AIO-Studien-gGmbHRoche Pharma AGCompletedAdenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the StomachGermany
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-positive Breast CancerBrazil
-
Lucia Del Mastro,MDCompleted
-
Dawn L. HershmanNational Cancer Institute (NCI); Incyte CorporationCompletedMetastatic Breast Cancer | Breast Carcinoma | HER-2 Positive Breast CancerUnited States
-
Genor Biopharma Co., Ltd.Completed
-
Infinity Pharmaceuticals, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | HER2 Positive Breast Cancer | Cancer of the BreastUnited States, Spain
-
Institute of Cancer Research, United KingdomNovartis; Cancer Research UK; Manchester University NHS Foundation Trust; University...Active, not recruitingBreast CancerUnited Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, France, Sweden, Canada, Finland, Italy, Greece, Mexico, Costa Rica, Poland, Brazil, Guatemala, Panama
-
Institut Català d'OncologiaFundación Sociedad Española de Oncologia Médica; Instituto de Salud Carlos III and other collaboratorsRecruitingNeoplasms | Breast Cancer | HER2-positive Breast CancerSpain
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruiting
-
R-PharmCompletedMetastatic Breast CancerItaly, Turkey, Spain, France, Greece
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, United States, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZeneca UK LimitedRecruitingBreast Cancer | Non-small Cell Lung CarcinomaUnited States, Spain, France, United Kingdom
-
City of Hope Medical CenterActive, not recruitingAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric Cancer and other conditionsUnited States
-
UNICANCERSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Leptomeningeal Disease | Leptomeningeal MetastasisFrance
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastUnited States, France, Ireland
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Genentech, Inc.CompletedBreast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingColorectal Neoplasms | Ovarian Neoplasms | Solid Tumor | Gallbladder Neoplasms | Prostatic Neoplasm | Pancreatic Neoplasm | Lung Neoplasm | Haematological Malignancy | Urinary Bladder Neoplasm | Skin Neoplasm | Salivary Gland NeoplasmUnited Kingdom
-
Dr Rajendra A. BadweTata Memorial HospitalRecruitingHER2 Positive Breast Cancer | Carcinoma Breast Stage IIndia
-
Shanghai Henlius BiotechCompleted
-
Dana-Farber Cancer InstituteGenentech, Inc.; ExelixisCompletedBreast Cancer | Brain Tumor - MetastaticUnited States
-
Cogent Biosciences, Inc.TerminatedSolid Tumor | HER-2 Protein OverexpressionUnited States
-
Hoffmann-La RocheCompletedBreast CancerCanada, Spain, France, United Kingdom, Italy
-
MedSIRTerminatedAdvanced Breast CancerSpain
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.RecruitingHER2-positive Breast Cancer | Leptomeningeal Disease | Leptomeningeal MetastasisUnited States
-
Genentech, Inc.Active, not recruitingSolid TumorsUnited States, Italy, Korea, Republic of, Spain, Denmark, Taiwan, Australia, France, Netherlands, United Kingdom, Singapore, Belgium, Japan, Canada